Skip to main content

Advertisement

Log in

A Novel Single Nucleotide Polymorphism in XRCC4 Gene is Associated with Gastric Cancer Susceptibility in Taiwan

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The DNA repair gene XRCC4, an important caretaker of the overall genome stability, is thought to play a major role in the human carcinogenesis. We investigate some novel and important polymorphic variants of XRCC4, at codon 247 (rs3734091), G-1394T (rs6869366), intron 3 (rs28360071), and intron 7 (rs28360317), of their associated with gastric cancer susceptibility.

Materials and Methods

In this hospital-based case-control study, the association of XRCC4 polymorphisms with gastric cancer risk in a Taiwanese population was investigated. In total, 121 patients with gastric cancer and 121 age-matched healthy controls recruited were genotyped investigating these polymorphisms’ association with gastric cancer susceptibility.

Results

We found a significant difference in the frequency of the XRCC4 G-1394T genotype, but not others, between the gastric cancer and control groups. Those who had G/T or G/G at XRCC4 G-1394T showed a 3.79-fold (95% confidence interval = 1.47–9.82) increased risk of gastric cancer compared to those with T/T. As for XRCC4 codon 247, intron 3, or intron 7, there was no difference in distribution between the gastric cancer and control groups.

Conclusions

Our findings suggest that the G allele of the XRCC4 G-1394T may contribute to gastric carcinogenesis and may be useful for gastric cancer early detection and prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.

Similar content being viewed by others

References

  1. Steward BW. WHO: World Cancer Report 2003. Lyon, France: International Agency for Research on Cancer, 2004

    Google Scholar 

  2. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333:32–41

    Article  PubMed  CAS  Google Scholar 

  3. Zhu S, Mason J, Shi Y, et al. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin Med J (Engl) 2003; 116:15–9

    CAS  Google Scholar 

  4. Rossi E, Hung J, Beilby JP, et al. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia. Ann Epidemiol 2006; 16:206–12

    Article  PubMed  Google Scholar 

  5. Zhang SM, Moore SC, Lin J, et al. Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol 2006; 163:108–15

    Article  PubMed  Google Scholar 

  6. Larsson SC, Giovannucci E, Wolk A. A prospective study of dietary folate intake and risk of colorectal cancer: modification by caffeine intake and cigarette smoking. Cancer Epidemiol Biomarkers Prev 2005; 14:740–3

    Article  PubMed  CAS  Google Scholar 

  7. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 2005; 113:825–8

    Article  PubMed  CAS  Google Scholar 

  8. Powers HJ. Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J Nutr 2005; 135:2960S–6S

    PubMed  CAS  Google Scholar 

  9. Voorrips LE, Goldbohm RA, Brants HA, et al. A prospective cohort study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000; 9:357–65

    PubMed  CAS  Google Scholar 

  10. Vogelstein B, Alberts B, Shine K. Genetics. Please don’t call it cloning! Science 2002; 295:1237

    Article  PubMed  Google Scholar 

  11. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 2005; 162:925–42

    Article  PubMed  Google Scholar 

  12. Kirk BW, Feinsod M, Favis R, Kliman RM, Barany F. Single nucleotide polymorphism seeking long term association with complex disease. Nucleic Acids Res 2002; 30:3295–311

    Article  PubMed  CAS  Google Scholar 

  13. Li Z, Otevrel T, Gao Y, et al. The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell 1995; 83:1079–89

    Article  PubMed  CAS  Google Scholar 

  14. Mari PO, Florea BI, Persengiev SP, et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc Natl Acad Sci USA 2006; 103:18597–602

    Article  PubMed  CAS  Google Scholar 

  15. van Heemst D, Brugmans L, Verkaik NS, van Gent DC. End-joining of blunt DNA double-strand breaks in mammalian fibroblasts is precise and requires DNA-PK and XRCC4. DNA Repair (Amst) 2004; 3:43–50

    Article  Google Scholar 

  16. Gao Y, Ferguson DO, Xie W, et al. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 2000; 404:897–900

    Article  PubMed  CAS  Google Scholar 

  17. Gao Y, Sun Y, Frank KM, et al. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 1998; 95:891–902

    Article  PubMed  CAS  Google Scholar 

  18. Fu YP, Yu JC, Cheng TC, et al. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res 2003; 63:2440–6

    PubMed  CAS  Google Scholar 

  19. Bau DT, Fu YP, Chen ST, et al. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. Cancer Res 2004; 64:5013–9

    Article  PubMed  CAS  Google Scholar 

  20. Bau DT, Mau YC, Shen CY. The role of BRCA1 in non-homologous end-joining. Cancer Lett 2006; 240:1–8

    PubMed  CAS  Google Scholar 

  21. Allen-Brady K, Cannon-Albright LA, Neuhausen SL, Camp NJ. A role for XRCC4 in age at diagnosis and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15:1306–10

    Article  PubMed  CAS  Google Scholar 

  22. Bau DT, Tsai MH, Huang CY, et al. Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit. Chinese J Physiology 2007; 50:1–4

    Google Scholar 

  23. Bau DT, Tsai MH, Lo YL, et al. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. Anticancer Res 2007; 27:1559–64

    PubMed  CAS  Google Scholar 

  24. Hanaoka T, Sugimura H, Nagura K, et al. hOGG1 exon7 polymorphism and gastric cancer in case–control studies of Japanese Brazilians and non-Japanese Brazilians. Cancer Lett 2001; 170:53–61

    Article  PubMed  CAS  Google Scholar 

  25. Huang GP, Zheng ZL, Cai L. DNA repair gene XRCC3 Thr241Met polymorphism and susceptibility to cardia and non-cardia gastric cancer: a case-control study. Zhonghua Liu Xing Bing Xue Za Zhi 2006; 27:420–3

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Chia-Wen Tsai, Hsiu-Yun Liang, and Chiao-Lin Lin for their technical assistance. This study was supported by research grants from the China Medical University Hospital (DMR-96-002), Terry Fox Cancer Research Foundation and the National Science Council (NSC 95-2320-B-039-014-MY3, second year).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Da-Tian Bau PhD.

Additional information

C.-F. Chiu and C.-H. Wang contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiu, CF., Wang, CH., Wang, CL. et al. A Novel Single Nucleotide Polymorphism in XRCC4 Gene is Associated with Gastric Cancer Susceptibility in Taiwan. Ann Surg Oncol 15, 514–518 (2008). https://doi.org/10.1245/s10434-007-9674-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9674-3

Keywords

Navigation